Skip to main content

Table 6 Clinical analysis used for the follow up.

From: Financial risk of increasing the follow-up period of breast cancer treatment currently covered by the Social Protection System in Health in México

Carcinoembryonic antigen (ACE)

CA 15.3 antigen

CA 27–29 antigen

Biometry or complete cytology

Serum calcium

Immunofluorescence

Lipid profile (triglycerides, total cholesterol, LDL and HDL)

Liver function tests

Blood chemistry 3 elements

Densitometry 1 region

Bone gammagram with technetium

Bilateral mammography

PET-CT-FDG

Radiography 1 projection

MRI of the abdomen and pelvis

Computerized axial tomography without contrast of each one of the regions of the body

Liver ultrasound

Bilateral bilateral ultrasound